| scholarly article | Q13442814 |
| P2093 | author name string | J. Weiss | |
| A. Horwitz | |||
| G. Theofan | |||
| L. Grinna | |||
| P. Elsbach | |||
| Gazzano-Santoro H | |||
| T. Parsons | |||
| P. J. Conlon | |||
| J. B. Parent | |||
| H. Gazzano-Santoro | |||
| P2860 | cites work | A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis. | Q46536693 |
| A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum | Q46622394 | ||
| The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope | Q50208372 | ||
| A 25-kDa NH2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein. | Q54397174 | ||
| Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification | Q69338119 | ||
| Structure and function of lipopolysaccharide binding protein | Q24324774 | ||
| Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations | Q24339484 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells | Q34017706 | ||
| Antibiotic proteins of human neutrophils | Q34262671 | ||
| Biochemistry of endotoxins | Q34564256 | ||
| Endotoxic-lipopolysaccharide-specific binding proteins on lymphoid cells of various animal species: association with endotoxin susceptibility. | Q35093718 | ||
| Lipopolysaccharide nomenclature--past, present, and future | Q36296221 | ||
| Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum | Q36352797 | ||
| Lipopolysaccharide structure determines ionic and hydrophobic binding of a cationic antimicrobial neutrophil granule protein | Q36996921 | ||
| Antimicrobial binding of a radiolabeled cationic neutrophil granule protein | Q37020367 | ||
| Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure | Q37021236 | ||
| Physiological effects of a bactericidal protein from human polymorphonuclear leukocytes on Pseudomonas aeruginosa | Q37053845 | ||
| Environmental modulation of lipopolysaccharide chain length alters the sensitivity of Escherichia coli to the neutrophil bactericidal/permeability-increasing protein | Q37056829 | ||
| Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate | Q37076566 | ||
| Lipid A and resistance of Salmonella typhimurium to antimicrobial granule proteins of human neutrophil granulocytes | Q37096862 | ||
| Specific detection of Haemophilus influenzae type b lipooligosaccharide by immunoassay | Q37193450 | ||
| Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy | Q37943123 | ||
| The case for specific lipopolysaccharide receptors expressed on mammalian cells | Q38211829 | ||
| Structure-activity relationships of bacterial lipopolysaccharides (endotoxins). Current and future aspects | Q39653046 | ||
| Endotoxins and disease mechanisms | Q39767274 | ||
| High-molecular-weight components in lipopolysaccharides of Salmonella typhimurium, Salmonella minnesota, and Escherichia coli | Q39980128 | ||
| The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment | Q40160543 | ||
| The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin | Q40738309 | ||
| Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes | Q40867899 | ||
| Reactivity of monoclonal antibody E5 with endotoxin. II. Binding to short- and long-chain smooth lipopolysaccharides | Q41505440 | ||
| Chimeric mouse-human anti-carcinoma antibodies that mediate different anti-tumor cell biological activities | Q41687865 | ||
| Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils. | Q41763332 | ||
| Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme | Q42217173 | ||
| Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity | Q43463435 | ||
| Cellular and subcellular localization of the bactericidal/permeability-increasing protein of neutrophils | Q43499274 | ||
| Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. | Q43748246 | ||
| Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship | Q45913463 | ||
| Reactivity of monoclonal antibody E5 with endotoxin. I. Binding to lipid A and rough lipopolysaccharides | Q45946874 | ||
| Expression of synthetic thaumatin genes in yeast | Q46087656 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipopolysaccharide | Q421804 |
| P304 | page(s) | 4754-4761 | |
| P577 | publication date | 1992-11-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide | |
| P478 | volume | 60 |
| Q33593645 | A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein |
| Q53568682 | A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis. |
| Q30882053 | A theoretical approach to spot active regions in antimicrobial proteins. |
| Q30363677 | Alternative sigma factor RpoE is important for Vibrio parahaemolyticus cell envelope stress response and intestinal colonization. |
| Q36603406 | An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains. |
| Q41513686 | Analysis of lipopolysaccharide binding by CD14 |
| Q30471677 | Annexins I and II bind to lipid A: a possible role in the inhibition of endotoxins |
| Q73991800 | Anti-neutrophil cytoplasmic antibodies directed against the bactericidal/permeability-increasing protein (BPI) in pediatric cystic fibrosis patients do not recognize N-terminal regions important for the anti-microbial and lipopolysaccharide-binding |
| Q78194911 | Anti-neutrophil cytoplasmic autoantibodies (ANCA) to bactericidal/permeability-increasing (BPI) protein recognize the carboxyl terminal domain |
| Q77787045 | Antiendotoxin strategies |
| Q34411550 | Antimicrobial activity of peptides derived from olive flounder lipopolysaccharide binding protein/bactericidal permeability-increasing protein (LBP/BPI) |
| Q35903904 | Antimicrobial activity of rabbit CAP18-derived peptides |
| Q35995535 | Antimicrobial aspects of inflammatory resolution in the mucosa: a role for proresolving mediators |
| Q38783727 | Apoptotic Cell Death Induced by ofLBP6A, Lipopolysaccharide Binding Protein Model Peptide, Derived from Paralichthy olivaceus on MKN-28 Cells |
| Q42088718 | Arabidopsis LBP/BPI related-1 and -2 bind to LPS directly and regulate PR1 expression. |
| Q27489093 | Autoantibodies in primary sclerosing cholangitis |
| Q36804240 | Bacteria in the intestine, helpful residents or enemies from within? |
| Q34528895 | Bactericidal activity of synthetic peptides based on the structure of the 55-kilodalton bactericidal protein from human neutrophils |
| Q60307394 | Bactericidal/Permeability-Increasing Protein Is an Enhancer of Bacterial Lipoprotein Recognition |
| Q40564213 | Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis |
| Q39471806 | Bactericidal/permeability-increasing protein inhibits growth of a strain of Acholeplasma laidlawii and L forms of the gram-positive bacteria Staphylococcus aureus and Streptococcus pyogenes |
| Q37639227 | Bactericidal/permeability-increasing protein originates in both the testis and the epididymis and localizes in mouse spermatozoa |
| Q40782925 | Bactericidal/permeability-increasing protein promotes complement activation for neutrophil-mediated phagocytosis on bacterial surface. |
| Q40375309 | Bactericidal/permeability-increasing protein protects vascular endothelial cells from lipopolysaccharide-induced activation and injury. |
| Q50141944 | Binding between lipopolysaccharide and cecropin A. |
| Q33535029 | Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives. |
| Q34775371 | Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials |
| Q39822193 | Characterization of the structural elements in lipid A required for binding of a recombinant fragment of bactericidal/permeability-increasing protein rBPI23. |
| Q39859611 | Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria. |
| Q39458333 | DUF538 protein super family is predicted to be the potential homologue of bactericidal/permeability-increasing protein in plant system |
| Q31976294 | Designed beta-sheet-forming peptide 33mers with potent human bactericidal/permeability increasing protein-like bactericidal and endotoxin neutralizing activities |
| Q35771793 | Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli |
| Q38319197 | Endothelial adhesion molecule expression and its inhibition by recombinant bactericidal/permeability-increasing protein are influenced by the capsulation and lipooligosaccharide structure of Neisseria meningitidis |
| Q42248495 | Enterohemorrhagic Escherichia coli O157:H7 gal mutants are sensitive to bacteriophage P1 and defective in intestinal colonization |
| Q24306653 | Expansion of the BPI family by duplication on human chromosome 20: characterization of the RY gene cluster in 20q11.21 encoding olfactory transporters/antimicrobial-like peptides |
| Q54299765 | Expression of bactericidal/permeability-increasing protein requires C/EBP epsilon. |
| Q42063076 | Fold-unfold transitions in the selectivity and mechanism of action of the N-terminal fragment of the bactericidal/permeability-increasing protein (rBPI(21)). |
| Q39822606 | Glycosphingolipids from Sphingomonas paucimobilis induce monokine production in human mononuclear cells. |
| Q24682905 | Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein |
| Q39821187 | Human lipopolysaccharide-binding protein potentiates bactericidal activity of human bactericidal/permeability-increasing protein. |
| Q39514295 | Human monocyte receptors involved in tumor necrosis factor responses to group B streptococcal products |
| Q37536487 | Importance of the residue 190 on bactericidal activity of the bactericidal/permeability-increasing protein 5. |
| Q39827113 | Induction of tumor necrosis factor production from monocytes stimulated with mannuronic acid polymers and involvement of lipopolysaccharide-binding protein, CD14, and bactericidal/permeability-increasing factor |
| Q24337402 | LPLUNC1 modulates innate immune responses to Vibrio cholerae |
| Q41998225 | Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide |
| Q33976703 | Lipopolyamines: novel antiendotoxin compounds that reduce mortality in experimental sepsis caused by gram-negative bacteria. |
| Q24310669 | Lipopolysaccharide-binding protein mediates CD14-independent intercalation of lipopolysaccharide into phospholipid membranes |
| Q42477868 | Lipopolysaccharide-induced E-selectin expression requires continuous presence of LPS and is inhibited by bactericidal/permeability-increasing protein |
| Q42789911 | Liver failure induces a systemic inflammatory response. Prevention by recombinant N-terminal bactericidal/permeability-increasing protein |
| Q35151343 | Mammalian antibiotic peptides |
| Q40942472 | Mediators and vascular effects in response to endotoxin. |
| Q37410325 | Mouse eosinophils possess potent antibacterial properties in vivo. |
| Q64956333 | Novel heterozygous BPIFC variant in a Chinese pedigree with hereditary trichilemmal cysts. |
| Q35128699 | Novelties in the field of antimicrobial compounds for the treatment of lower respiratory tract infections |
| Q33713662 | Of microbes and meals: the health consequences of dietary endotoxemia. |
| Q73225061 | Organ blood flow after partial hepatectomy in rats: modification by endotoxin-neutralizing bactericidal/permeability-increasing protein (rBPI23) |
| Q35082830 | Ovocalyxin-36 is a pattern recognition protein in chicken eggshell membranes |
| Q35075111 | Parental transfer of the antimicrobial protein LBP/BPI protects Biomphalaria glabrata eggs against oomycete infections |
| Q72181667 | Pathogenesis of hemorrhage-induced bacteria/endotoxin translocation in rats. Effects of recombinant bactericidal/permeability-increasing protein |
| Q40809002 | Pilot experience with opebacan/rBPI 21 in myeloablative hematopoietic cell transplantation |
| Q35516570 | Potent CD14-mediated signalling of human leukocytes by Escherichia coli can be mediated by interaction of whole bacteria and host cells without extensive prior release of endotoxin |
| Q33616880 | Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I |
| Q39821705 | Prolonged expression of lipopolysaccharide (LPS)-induced inflammatory genes in whole blood requires continual exposure to LPS. |
| Q35635915 | Protection of mice from lethal Escherichia coli infection by chimeric human bactericidal/permeability-increasing protein and immunoglobulin G1 Fc gene delivery |
| Q33753263 | Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia |
| Q35418279 | Reactivation of arthritis induced by small bowel bacterial overgrowth in rats: role of cytokines, bacteria, and bacterial polymers |
| Q35176262 | Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock |
| Q24550659 | Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii |
| Q40375029 | Recombinant human bactericidal/permeability-increasing protein (rBPI23) is a universal lipopolysaccharide-binding ligand. |
| Q35381513 | Role of endotoxin in acute inflammation induced by gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing protein |
| Q41729809 | Role of the bactericidal/permeability-increasing protein in host defence. |
| Q39148416 | Special pro-resolving mediator (SPM) actions in regulating gastro-intestinal inflammation and gut mucosal immune responses |
| Q35121455 | Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit gram-negative sepsis. |
| Q24673162 | The BPI/LBP family of proteins: a structural analysis of conserved regions |
| Q40883047 | The Vibrio cholerae ToxR-regulated porin OmpU confers resistance to antimicrobial peptides |
| Q36902238 | The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease. |
| Q40825150 | The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. |
| Q54615120 | The construction and characterization of colanic acid deficient mutants in an extraintestinal isolate of Escherichia coli (O4/K54/H5). |
| Q33719376 | The multifunctional host defense peptide SPLUNC1 is critical for homeostasis of the mammalian upper airway |
| Q46692260 | The role of liver and kidney on the pharmacokinetics of a recombinant amino terminal fragment of bactericidal/permeability-increasing protein in rats |
| Q36628085 | Time-resolved fluoroimmunoassay for bactericidal/permeability-increasing protein |
| Q73690824 | Use of native and recombinant bactericidal/permeability-increasing proteins (BPI) as antigens for detection of BPI-ANCA |
| Q35632357 | Use of steroids to monitor alterations in the outer membrane of Pseudomonas aeruginosa |
| Q33520240 | rBPI(21) promotes lipopolysaccharide aggregation and exerts its antimicrobial effects by (hemi)fusion of PG-containing membranes |
Search more.